ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,930.85
1.09%
Dow Jones
42,840.26
1.18%
US Dollar vs MXN
20.0813
0.00%
Brent Oil
72.72
0.00%
Bitcoin
95,828.36
-1.42%
Pepperstone
Advertisement
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Biophytis (ALBPS) Cotización

Biophytis

Biophytis (ALBPS)

EU
0.34
0.004
(1.19%)
Cerrado 21 Diciembre 10:30AM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
0.34
Postura de Compra
0.3225
Postura de Venta
0.345
Volume Operado de la Acción
29,437
0.3261 Rango del Día 0.34
0.0021 Rango de 52 semanas 1.40
Capitalización de Mercado [m]
100.539M
Precio Anterior
0.336
Precio de Apertura
0.34
Hora
200
@
0.34
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
38,896
Acciones en circulación
295,702,507
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-5.90
Beneficio por acción (BPA)
-0.06
turnover
-
Beneficio neto
-17.03M

Acerca de Biophytis

Sector
Biological Pds,ex Diagnstics
Industria
Biological Pds,ex Diagnstics
Sitio web
www.biophytis.com
Sede
Paris, Paris, Fra
Fundado
-
Biophytis is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker ALBPS. The last closing price for Biophytis was 0.34 €. Over the last year, Biophytis shares have traded in a share price range of 0.0021 € to 1.40 €.

Biophytis currently has 295,702,507 shares in issue. The market capitalisation of Biophytis is 99.36 € million. Biophytis has a price to earnings ratio (PE ratio) of -5.90.

ALBPS Últimas noticias

Más noticias

Biophytis to Restate Previously Issued Financial Statements

PARIS and CAMBRIDGE, Mass., Oct. 06, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (NasdaqCM: BPTS, Euronext Growth Paris: ALBPS) (the “Company” or “Biophytis”), a clinical-stage biotechnology company...

06 Octubre 2021
GlobeNewswire Inc.

Biophytis Receives FDA IND Clearance for COVA, a Phase 2/3 Clinical Trial with Sarconeos (BIO101) for the Treatment of Patien...

PARIS and CAMBRIDGE, Mass., July 02, 2020 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company specialized in the development of drug...

02 Julio 2020
GlobeNewswire Inc.

Biophytis Announces Results of 2019 Annual General Meeting of Shareholders

All resolutions within the competence of the Ordinary General Meeting adoptedSecond notice to reconvene the Extraordinary General Meeting to be held in the coming weeks PARIS and CAMBRIDGE...

28 Junio 2019
GlobeNewswire Inc.

Biophytis Enters into a Collaboration with the French Muscular Dystrophy Association (AFM-Telethon)

Provides funding for additional preclinical experiments and for the MYODA preparations for the clinical study in Duchenne muscular dystrophy (DMD) PARIS and CAMBRIDGE, Mass., June 13, 2019...

13 Junio 2019
GlobeNewswire Inc.

Biophytis Expands Daniel Schneiderman’s Role to Group Chief Financial Officer

PARIS and CAMBRIDGE, Mass., June 07, 2019 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics for...

07 Junio 2019
GlobeNewswire Inc.

Biophytis Announces Publication of its 2018 Annual Report

Files 2018 Annual Report with the AMFProvides first quarter 2019 financial statementsEnters into intellectual property agreement with Stanislas Veillet PARIS and CAMBRIDGE, Mass., May 22, 2019...

22 Mayo 2019
GlobeNewswire Inc.

Biophytis Files Registration Statement for Proposed Initial Public Offering in the United States

PARIS and CAMBRIDGE, Mass., May 22, 2019 (GLOBE NEWSWIRE) -- Biophytis (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of therapeutics for...

22 Mayo 2019
GlobeNewswire Inc.

Biophytis Reports Annual 2018 Financial Results and Provides Operational Update

Clinical execution and advancement of our SARA program, including initiation of the SARA-INT Phase 2b clinical trial for sarcopeniaLaunch of our MYODA program for Duchenne muscular dystrophy...

11 Marzo 2019
GlobeNewswire Inc.

Biophytis Announces Three Oral and One Poster Presentations at the 2019 International Conference on Frailty and Sarcopenia Re...

PARIS, Feb. 18, 2019 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company focused on the development of novel therapeutics for age-related...

18 Febrero 2019
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.026.250.320.340.315228750.32792902DE
40.046815.96180081860.29320.340.293219420.31061308DE
12-0.06-150.40.42990.28388960.32395084DE
26-0.4814-58.60725590460.82141.40.28564260.51814087DE
520.33314827.536231880.00691.40.002167630180.00597693DE
156-0.11-24.44444444440.451.40.002154588570.02997961DE
2600.13162.67942583730.2092.730.002147293890.27486897DE

ALBPS - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Biophytis?
El precio actual de las acciones de Biophytis es 0.34 €
¿Cuántas acciones de Biophytis están en circulación?
Biophytis tiene 295,702,507 acciones en circulación
¿Cuál es la capitalización de mercado de Biophytis?
La capitalización de mercado de Biophytis es EUR 99.36M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Biophytis?
Biophytis ha negociado en un rango de 0.0021 € a 1.40 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Biophytis?
El ratio precio/beneficio de Biophytis es -5.9
¿Cuál es la moneda de reporte de Biophytis?
Biophytis presenta sus resultados financieros en EUR
¿Cuál es el último beneficio anual de Biophytis?
El último beneficio anual de Biophytis es EUR -17.03M
¿Cuál es la dirección registrada de Biophytis?
La dirección registrada de Biophytis es 14 AVENUE DE L’OPERA, PARIS, PARIS, 75001
¿Cuál es la dirección del sitio web de Biophytis?
La dirección del sitio web de Biophytis es www.biophytis.com
¿En qué sector industrial opera Biophytis?
Biophytis opera en el sector BIOLOGICAL PDS,EX DIAGNSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TMBSZTME Pharma NV
0.02 €
(185.71%)
132.5k
MLGEQGentlemen S Equity SA
0.0175 €
(118.75%)
1.14k
ALCYBCybergun
0.0002 €
(100.00%)
17.54M
MLAAHAmatheon Agri Holding NV
0.0185 €
(54.17%)
40.1k
ALARFAdeunis
0.94 €
(28.77%)
5.27k
MLSMLSmalto
0.0125 €
(-37.50%)
2.34k
MLFTIFrance Tourisme Immobilier
0.025 €
(-35.90%)
56.77k
CNVCnova NV
0.209 €
(-19.62%)
26.38k
MLWEAWeaccess Group
0.382 €
(-16.96%)
5.95k
ALEUPEuroplasma
0.0353 €
(-15.95%)
3.16M
ATOAtos SE
0.0021 €
(0.00%)
2.71B
BCPBanco Comercial Portugues SA
0.4493 €
(-0.69%)
66.54M
ALHGLouis Hachette Group
1.3342 €
(4.87%)
52.04M
KPNKoninklijke KPN NV
3.509 €
(-1.21%)
26.9M
VIVVivendi SE
2.51 €
(2.41%)
26.39M

Discusión

Ver feed completo
Pickme2 Pickme2 9 minutos hace
Then ConDog and LittleMax can gagg togather
ATMH
lambchops lambchops 9 minutos hace
Merry Christmas to you Dripper! And everyone else too!

LC

SIPC
SIPC
shajandr shajandr 11 minutos hace
Billy is brangin' huge presents for all UOIP baggholders. Autographed first editions of his new bestseller
shajandr shajandr 12 minutos hace
JUAN LUIS MATOS' new Adios El Dinero strip club Grande Openings featuring Louetta dancing the pole and $6 Tecates from 4PM-7PM.
nowwhat2 nowwhat2 12 minutos hace
SEASONS' GREETINGS


https://investorshub.advfn.com/uimage/uploads/2024/12/21/hzybsBTC_121212_21_45d_8PM_SEASON_GRINCH_MAG_CALV_100K.jpg


https://investorshub.advfn.com/uimage/uploads/2024/12/21/sqjwyBTC_121212_21_CAPT_845pm_SEASON_GRINCH.jpg
XRPUSD
BDEZ BDEZ 13 minutos hace
Jerome Powell has said that "we're not allowed to own bitcoin"

https://x.com/unusual_whales/status/1870545019750478084
shajandr shajandr 13 minutos hace
Let's play The Prison Game with our host DAVID RUSSELL FOLEY USBOP Inmate No. 13141-111.

Roly-poly FOLEY
NTGL
BDEZ BDEZ 13 minutos hace
Jerome Powell has said that "we're not allowed to own bitcoin"

https://x.com/unusual_whales/status/1870545019750478084
Gregg4 Gregg4 17 minutos hace
Where
ESPR
nowwhat2 nowwhat2 22 minutos hace
SEASONS' GREETINGS


https://investorshub.advfn.com/uimage/uploads/2024/12/21/hzybsBTC_121212_21_45d_8PM_SEASON_GRINCH_MAG_CALV_100K.jpg




https://investorshub.advfn.com/uimage/uploads/2024/12/22/jswjzbtc_121212_21_snip_9pm_grinch_whump.jpg
BTCUSD
KILLAZILLA KILLAZILLA 23 minutos hace
WHERE'S your PROOF!!!!!!!+!!!!
XERI
igotthemojo igotthemojo 24 minutos hace
" nothing about the three pillars requirements which were proposed in the preliminary rules, unless buried in this attachment, which itself has links to literally hundreds of other attachments."

the 3 pillars was probably the #1 issue many had with the 45v...if the change was not feat
FCEL
SkyLimit2022 SkyLimit2022 27 minutos hace
Gus,

It’s not DCVax-L.

NWBO now owns the commercial rights to TWO distinct dendritic cell vaccine technologies (and there may be other licensing deals that have not been announced yet).

DCVax-L is the technology that NWBO licensed from UCLA, and the othe
NWBO
surfer44 surfer44 28 minutos hace
Not much. Average 11,000 shares.
TOPS
SSKILLZ1 SSKILLZ1 28 minutos hace
Savvy Pick 10 Contest #1 Results In (Week 25)

Hope everyone enjoys the stats. Below is the link to the board. Have a great weekend everyone.

https://investorshub.advfn.com/Savvy-Pick-10-Contest-1-43057
SSKILLZ1 SSKILLZ1 29 minutos hace
Savvy Pick 10 Contest #1 Results In (Week 25)

Hope everyone enjoys the stats. Below is the link to the board. Have a great weekend everyone.

https://investorshub.advfn.com/Savvy-Pick-10-Contest-1-43057
The Great Pumpkin The Great Pumpkin 29 minutos hace
Ready to accept your apology for the unhinged PM’s you sent me. Let me know when you want to get that off your conscience. As always just trying to help people see the truth and not lose money.

#scam
LWLG
Richie R Richie R 30 minutos hace
Shopping for a stock trade here..
Gus1212 Gus1212 34 minutos hace
I hope it is DCVAX but I don't think this is.
Someone make my day and tell me I am wrong.

Why and how can they be making the vaccine at the Moffitt Center? (As they stated)
This is my big doubt

UCLA OK Moffitt Center ????
NWBO
Green Leaf Smoker Green Leaf Smoker 35 minutos hace
As one has proven obviously love is blind
PHIL
janice shell janice shell 35 minutos hace
Oh my! You lead a very rich fantasy life indeed!
CashCowMoo CashCowMoo 37 minutos hace
Some decent news has been out the past couple months. Looks like they are trying to get ready for a decent 2025 after this winter. Im not in yet, but still watching and may jump in soon.
GXRFF
hap0206 hap0206 37 minutos hace
you can hope it goes that way -- but much more likely

war on fossil fuels ends -- energy costs cut in half -- Trump tax cuts made permanent

Mexico stops the migrants -- border is closed

EU/Canada rearms -- Russia goes bankrupt

Iran is cru
52172 52172 38 minutos hace
Keep marching 20's imminent 
ARQT

Su Consulta Reciente

EU
ALBPS
Biophytis
BOV
F1BH34
Fortune Brands Innovations
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados